Sorafenib and hepatic arterial infusion chemotherapy for unresectable advanced hepatocellular carcinoma: A comparative study

Sorafenib is a kinase-targeted drug that has high efficacy for advanced hepatocellular carcinoma (HCC). The aim of the present study was to determine whether sorafenib is more effective than hepatic arterial infusion chemotherapy (HAIC) for HCC. Twenty patients treated with sorafenib (sorafenib grou...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: HIRAMINE, YASUNARI, UTO, HIROFUMI, IMAMURA, YASUSHI, TABU, KAZUAKI, BABA, YOSHIROU, HIWAKI, TAKUYA, SHO, YUKIHIKO, TAHARA, KENJI, HIGASHI, HIROFUMI, TAMAI, TUTOMU, OKETANI, MAKOTO, IDO, AKIO, TSUBOUCHI, HIROHITO
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2011
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3440737/
https://ncbi.nlm.nih.gov/pubmed/22977522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2011.237
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires